150 related articles for article (PubMed ID: 19154222)
1. Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
Uchida H; Suzuki T; Watanabe K; Kashima H
Psychiatry Clin Neurosci; 2009 Feb; 63(1):126. PubMed ID: 19154222
[No Abstract] [Full Text] [Related]
2. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
3. MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.
Mihaljevic Peles A; Bozina N; Sagud M; Rojnic Kuzman M; Lovric M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1439-44. PubMed ID: 18550244
[TBL] [Abstract][Full Text] [Related]
4. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
Schönfeldt-Lecuona C; Connemann BJ; Wolf RC; Braun M; Freudenmann RW
Pharmacopsychiatry; 2006 Jul; 39(4):152-4. PubMed ID: 16871471
[TBL] [Abstract][Full Text] [Related]
5. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
[TBL] [Abstract][Full Text] [Related]
6. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
Luis Blay S
Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
[No Abstract] [Full Text] [Related]
7. [Effect of neuroleptics on depressive symptoms].
Tabeze JP
Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
[No Abstract] [Full Text] [Related]
8. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
[TBL] [Abstract][Full Text] [Related]
9. Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
Chan JH; Chen CH; Robson D; Tan HK
Psychiatry Clin Neurosci; 2009 Feb; 63(1):125-6. PubMed ID: 19154221
[No Abstract] [Full Text] [Related]
10. Augmentation of paroxetine with clocapramine in panic disorder.
Saito M; Miyaoka H
Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675
[No Abstract] [Full Text] [Related]
11. Using psychostimulants for treating residual symptoms in major depression.
Berlim MT; Turecki MG
J Psychiatry Neurosci; 2007 Jul; 32(4):304. PubMed ID: 17653297
[No Abstract] [Full Text] [Related]
12. Exacerbation of extrapyramidal symptoms with paroxetine.
Arya DK; McKenzie J; Worrall N
Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
[No Abstract] [Full Text] [Related]
13. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
[TBL] [Abstract][Full Text] [Related]
14. The modern pharmacopoeia: a return to depressive realism?
Goldberg JF
Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
[No Abstract] [Full Text] [Related]
15. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
Kumagai R; Ichimiya Y
Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
[No Abstract] [Full Text] [Related]
16. The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.
Sagud M; Pivac N; Mustapic M; Nedic G; Peles AM; Kramaric M; Jakovljevic M; Muck-Seler D
Psychopharmacology (Berl); 2008 May; 197(4):683-5. PubMed ID: 18246328
[No Abstract] [Full Text] [Related]
17. High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.
Windhagen A; Wurster U; Kropp S; Ziegenbein M
Aust N Z J Psychiatry; 2006; 40(11-12):1039-41. PubMed ID: 17054574
[No Abstract] [Full Text] [Related]
18. Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression.
Hayashi H; Akahane T; Suzuki H; Sasaki T; Kawakatsu S; Otani K
Clin Neuropharmacol; 2010; 33(1):48-9. PubMed ID: 19935408
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of milnacipran by risperidone in treatment for major depression.
Tani K; Takei N; Kawai M; Suzuki K; Sekine Y; Toyoda T; Minabe Y; Mori N
Int J Neuropsychopharmacol; 2004 Mar; 7(1):55-8. PubMed ID: 14731310
[TBL] [Abstract][Full Text] [Related]
20. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
Reznik AM; Arbuzov AL; Khurbatova IG
Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
